Deferasirox improves outcomes at acceptable cost

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.572, 2009-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tiotropium bromide improves outcomes, QOL at acceptable cost

Inpharma, Vol. 1, Iss. 1426, 2004-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Tiotropium bromide improves outcomes, QOL at acceptable cost

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 447, 2004-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Eszopiclone settles insomnia at acceptable cost

Inpharma, Vol. 1, Iss. 1495, 2005-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Telemanagement improves HF outcomes

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 407, 2003-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Anidulafungin improves outcome at no extra cost

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 633, 2011-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite